Mapping inducible transcription factors has shown that the Edinger-Westphal nucleus is preferentially sensitive to alcohol intoxication. Herein, we characterize the pharmacological and signal transduction mechanisms related to alcohol-induced cFos expression in Edinger-Westphal neurons. Using immunohistochemistry, we show that pretreatment with ␥-aminobutyric acid (GABA)-ergic antagonists (4 mg/kg bicuculline and 45 mg/kg pentylenetetrazole) attenuates induction of c-Fos expression by alcohol (2.4 g/kg, intraperitoneal). In addition, 10 mg/kg 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)4,5-dihydro-1H-imidazole (RX 821002), an ␣ 2A/D -adrenoceptor antagonist, and 20 mg/kg haloperidol, a dopamine antagonist, also block alcohol-induced c-Fos expression in Edinger-Westphal neurons. No effects were seen in alcohol-induced c-Fos after the pretreatment of 20 mg/kg propranolol (␤-adrenoceptor antagonist), 10 mg/kg 2-(2-(4-(2-methoxyphenyl)piperazin-1-yl) ethy)-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione dihydrochloride (ARC 239) (␣ 2B/C -adrenoceptor antagonist), or 30 mg/kg naltrexone (opioid antagonist). Although positive modulators for the GABA A receptor (20 mg/kg 3␣-hydroxy-5␣-pregnan-20-one and 10 -30 mg/kg chlordiazepoxide) and opioid receptor (10 mg/kg morphine) produced significant elevations, agonists for ␣ 2 -adrenoceptors (clonidine) and dopamine receptors (apomorphine) had no effect on Edinger-Westphal c-Fos expression. These findings suggest that alcohol-induced c-Fos expression in Edinger-Westphal results from direct interactions with GABA A receptors, which are modified by ␣ 2A/D -adrenoceptors and dopamine receptors. Also using immunohistochemistry to identify potential intracellular mechanisms associated with alcohol-induced c-Fos expression in Edinger-Westphal, we show time-dependent increases in serine 727 phospho-signal transducer and activator of transcription 3 (Stat3) but no changes in phospho-cAMP response element-binding protein and phospho-Elk1. Time-dependent increases in phospho-extracellular signal-regulated kinase (ERK) 1/2 were found to occur simultaneously with increases in serine 727 phospho-Stat3. Finally, blockade of ERK 1/2 phosphorylation with the mitogen-activated protein kinase (MEK) 1/2 inhibitor SL327 blocked alcohol-induced c-Fos expression, suggesting that alcohol induces c-Fos in Edinger-Westphal neurons through activation of the MEK1/2-ERK1/2-Stat3 pathway.
Alcoholism is characterized by pathological patterns of alcohol use, which are thought to involve unique subsets of neural systems. The identification and characterization of neural targets is important to the understanding and the development of treatments. Mapping of inducible transcription factors (ITFs) encoded by immediate early genes in animals provides a valuable tool for identifying targets during alcohol intoxication (Herdegen and Leah, 1998) . ITFs from the Fos family are commonly used in mapping studies due to their low basal expression and increases after drug treatment, which are thought to result from increased neuronal activity (Morgan et al., 1987) . ITF brain mapping after involuntary alcohol administration has identified several brain regions showing c-Fos elevations (Chang et al., 1995; Thiele et al., 1996) . Interestingly, we have shown a much different pattern of expression after voluntary alcohol drinking in mice (Bachtell et al., 1999) . Specifically, c-Fos induction was not observed in brain regions showing strong reactivity to alcohol injections, including the lateral portion of the central nucleus of amygdala, bed nucleus of the stria terminalis, paraventricular nucleus of the thalamus, and paraventricular nucleus of the hypothalamus. Importantly, the Edinger-Westphal nucleus (EW) showed comparable levels after both voluntary and involuntary administrations. These results agree with other reports demonstrating EW's involvement in alcohol self-administration (Topple et al., 1998; Weitemier et al., 2001) .
The EW has received limited attention in alcohol research because of its association with oculomotor functions. However, mounting evidence suggests that the EW is involved in other functions, including temperature regulation, nociception, and anxiety (Loewy et al., 1978; Innis and Aghajanian, 1986; Smith et al., 1998; Weninger et al., 1999) . Moreover, the EW is the main brain source of the neuropeptide urocortin, the alternative and strongest ligand of corticotropin-releasing factor receptors (Vaughan et al., 1995) . Our recent studies using inbred strains suggest that urocortin-containing neurons of EW are involved in regulation of alcohol-induced hypothermia and alcohol consumption in mice (Bachtell et al., 2002) . Therefore, it is essential to characterize the mechanisms of alcohol-induced c-Fos expression in EW neurons. To this aim, we sought to characterize the pharmacological and signal transduction nature of alcohol-induced c-Fos expression in the EW.
The presence of postsynaptic ␣ 2 -adrenoceptors in EW seems to play a large role in the pupillary dilation response (i.e., mydriasis) (Heal et al., 1995) . In addition, pharmacological studies using benzodiazepines suggest the involvement of GABA A receptors in activating EW neurons (Cutrera et al., 1993; Skelton et al., 2000) . Other evidence shows that microinjections of opioid agonists (e.g., morphine and fentanyl) into the EW produce behavioral effects without significantly modulating mydriasis (Kamenetsky et al., 1997) . Thus, the opioid system may play a role in nonmydriatic behaviors stemming from EW neurons. In addition to these receptor systems, tyrosine hydroxylase-containing projections stemming from the highly dopaminergic ventral tegmental area suggest that the dopaminergic system may also play a role. Therefore, these four transmitter systems were tested for their involvement in alcohol-induced c-Fos expression in EW neurons.
The second part of this study analyzing the signal transduction mechanisms in the EW was based on previous reports showing that alcohol administration elevates expression of c-Fos, but does not elevate expression of ITF Egr1 (also known as NGFI-A, Zif268, and Krox-24) in EW (Bachtell et al., 1999; Bachtell and Ryabinin, 2001 ). The promoter regions of c-fos and egr1 genes contain several common regulatory elements, including the serum response element (SRE) and the calcium/cAMP response element (Ca/CRE). On the other hand, the c-fos promoter contains the c-Sis inducible element (SIE), whereas the egr1 promoter does not (Herdegen and Leah, 1998) . We hypothesized, therefore, that alcohol induces c-Fos mainly via an element that is unique to the c-Fos promoter. To address this hypothesis we used immunohistochemistry to analyze the signal transduction machinery not only acting through the SRE and Ca/CRE pathway (the CREB and Elk1 transcription factors), but also acting through the SIE mechanism (the STAT proteins).
Materials and Methods
Animals. Male C57BL/6J mice purchased from Jackson Laboratories (Bar Harbor, ME) were placed four per cage for a minimum of 1 week. All animals were 7 to 9 weeks of age at the beginning of the experimental procedure. Although other strains were considered, C57BL/6J mice were selected for this analysis because of the well characterized ITF expression in our previous experiments in the EW nucleus (Bachtell et al., 2002) . Animals were maintained on a 12-h light/dark cycle with lights on beginning at 6:00 AM. Water and food were available ad libitum throughout the experiment in the home cage. All animal procedures were in accordance with National Institutes of Health guidelines.
General Procedures. All animals were habituated to handling and injections on the 4 days before the drug treatment day. Our preliminary experiments have shown this procedure to be satisfactory in reducing basal c-Fos expression to minimal levels. During the habituation procedures, animals were exposed to two injections. All injections in all experiments were intraperitoneal. The second injection was made contralateral to the first injection. On the test day, animals were injected with the pretreatment drug and placed back into the home cage. Animals were injected again at precise intervals (depending on the drug properties), on the contralateral side, with the second injection (see specific experiments). Animals were then placed back into the home cage. Animals were sacrificed 100 min after the second injection by CO 2 inhalation. Animals were not perfused, however, brains were postfixed in 2% paraformaldehyde in phosphate-buffered saline (PBS) after removal. Brains were then immersed in 20% sucrose in PBS containing 0.1% NaN 3 for 24 h followed by two 24-h incubations in 30% sucrose in PBS containing 0.1% NaN 3 .
Immunohistochemistry. Immunohistochemistry was used because of the small size of EW and the difficulty in isolating it for Western blot analyses. All immunohistochemistry was performed according to previously published protocols (Bachtell et al., 1999) , unless otherwise noted. Briefly, frozen brains were sectioned into 40-m slices on a CM1850 cryostat (Leica Microsystems, Inc., Deerfield, IL). Blocking was performed with 4% goat serum. All primary antibodies were raised in rabbit, whereas the secondary antibodies were raised in goat (see specific experiments for antibody details). The immunoreaction was detected with Vectastain ABC kit (Vector Laboratories, Burlingame, CA), and enzymatic development was performed with the Metal Enhanced DAB kit (Pierce Chemical, Rockford, IL).
Data Analysis. Cell counting was performed using a quantitative image analysis system as reported previously (Bachtell et al., 1999) . Two slices containing EW were selected from each animal at approximately Ϫ3.00 to Ϫ3.40 from bregma as described by Franklin and Paxinos (1997) . Our preliminary experiments have determined that sections between Ϫ3.00 and Ϫ3.40 from bregma produce the most consistent results with c-Fos immunohistochemistry. To control for variability in 3,3-diaminobenzidine tetrachloride intensity, all statistical analyses were performed on sections processed simultaneously. Data from the two sections were averaged and used as a single data point for statistical analysis using an analysis of variance. Significant main and interactive effects were further analyzed with appropriate post hoc tests.
Experiment 1: Tests of GABA-ergic Involvement. The involvement of the GABA-ergic system in alcohol-induced c-Fos expression was first tested by pretreating animals (n ϭ 4 -6/group) with saline, the GABA A antagonist (Ϫ)-bicuculline (Sigma-Aldrich, St. Louis, MO), or the negative modulator of GABA A pentylenetetrazole (PTZ; Sigma-Aldrich) dissolved in saline. Ten minutes after the pretreatment, animals were injected with either saline or 2.4 g/kg alcohol (20% v/v in 0.9% saline). This dose of alcohol was previously shown to produce maximal c-Fos expression in EW neurons (Bachtell et al., 2002) . Two positive modulators at the GABA A site, 3␣-hydroxy-5␣-pregnan-20-one (3␣5␣-P, gift from Dr. Deborah Finn, Oregon Health and Science University, Portland, OR) and chlordiazepoxide (CDP, gift from Dr. Robert Hitzemann, Oregon Health and Science University) were dissolved in 2-hydroxypropyl-␤-cyclodextrin and saline, respectively, and were tested for their jpet.aspetjournals.org ability to induce c-Fos expression in the EW. A pretreatment of saline was administered 10 min before a vehicle, 3␣5␣-P, or CDP injection (n ϭ 4 -6/group). A group of animals (n ϭ 4) injected with 2.4 g/kg alcohol was also treated simultaneously to allow comparison of the GABA A effects with those produced by alcohol. In all cases, animals were sacrificed 100 min after the second injection and were analyzed for c-Fos (1:10,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) using the protocol described above.
Experiment 2: Tests of Opioid Involvement. The involvement of the opioid system was first tested with the pretreatment of saline or the opioid antagonist naltrexone (Sigma-Aldrich). Naltrexone was dissolved in saline and was administered 10 min before 2.4 g/kg alcohol (n ϭ 4 -8/group). The effects of morphine on c-Fos expression in EW were also tested. Morphine sulfate (Sigma-Aldrich) was dissolved in saline and was administered 10 min after a saline or naltrexone injection (n ϭ 4 -6/group). A group of animals (n ϭ 4) given a saline pretreatment and 2.4 g/kg alcohol was also included to allow comparison of the morphine's effects with those produced by alcohol. Animals were sacrificed 100 min after the second injection and analyzed for c-Fos immunohistochemistry as described above.
Experiment 3: Tests of Noradrenergic Involvement. The involvement of the noradrenergic system in alcohol-induced c-Fos expression in the EW was first tested with the pretreatment of either saline or nonselective antagonists for either the ␣-or the ␤-adrenoceptor. These included yohimbine (Tocris Cookson) and propranolol (Tocris Cookson), respectively, which were dissolved in saline. Ten minutes after the pretreatment of these compounds, animals (n ϭ 4 -8/group) were injected with either saline or 2.4 g/kg alcohol (20% v/v in 0.9% saline). These experiments were followed up by tests of selective ␣-adrenoceptor antagonists on alcohol-induced c-Fos expression. Thereby, 10 min before a 2.4-g/kg alcohol injection, pretreatments of saline vehicle, ARC 239 (␣ 2B/C -selective; Tocris Cookson), or RX 821002 (␣ 2A/D -selective; Tocris Cookson) were administered (Trendelenburg et al., 1996; Callado and Stamford, 1999) . To identify the involvement of the noradrenergic system in CDP-induced and morphine-induced EW c-Fos expression, these compounds were administered after yohimbine and RX 821002 (n ϭ 4/group), respectively. In addition to antagonists of the noradrenergic system, two ␣-adrenoceptor agonists were administered. The ␣ 2 -adrenoceptor agonist clonidine (Tocris Cookson) and the ␣ 1 -adrenoceptor agonist cirazoline (Tocris Cookson) were administered to separate groups of animals (n ϭ 4/group) after a saline pretreatment. Both compounds were dissolved in saline. In all cases, animals were sacrificed 100 min after the second injection and analyzed for c-Fos immunohistochemistry as described above.
Experiment 4: Morphological Characterization of Tyrosine Hydroxylase-Containing Neurons in the Edinger-Westphal Nucleus. Tyrosine hydroxylase (TH) is a biosynthetic precursor of both dopamine and noradrenaline. Its use herein was to morphologically characterize the noradrenaline-containing projections to EW neurons that contribute to the adrenergic effects on alcohol-induced c-Fos. A separate group of animals (n ϭ 4) was sacrificed and tyrosine-hydroxylase (1:1000; Chemicon International, Temecula, CA) was identified using immunohistochemistry protocols as described above.
Experiment 5: Tests of Dopaminergic Involvement. The involvement of the dopaminergic system in alcohol-induced c-Fos expression in the EW was tested first with the pretreatment of the dopamine antagonist haloperidol (Sigma-Aldrich), or DMSO vehicle. Twenty minutes after the pretreatment with haloperidol or DMSO, 2.4 g/kg alcohol was administered (n ϭ 5/group). In addition to the antagonist, the agonist apomorphine (gift from Dr. Charles Meshul, Oregon Health and Science University), was administered after a pretreatment of saline (n ϭ 5/group).
Experiment 6: Identification of the Signal Transduction Cascades. The following sequence of experiments was performed in animals that were habituated to saline injections (n ϭ 4 -8/group). On the final day, animals were injected with either saline or 2.4 g/kg alcohol. Unlike the previous experiments, animals were sacrificed by cervical dislocation at the following time points after the injection: 5, 15, or 30 min. Due to the use of antibodies detecting phosphorylated proteins, 1 mM NaF was added to all buffers and 0.1 mM NaF was added to all incubation solutions. With this exception, all immunohistochemical steps were identical to that presented above. Final dilutions of the primary antibodies were determined through preliminary experiments. We first tested antibodies detecting the primary substrate of SRE phospho-(Ser 383)-Elk1 (1:100; Cell Signaling Technology, Beverly, MA). We next targeted substrates of Ca/CRE, including CREB (1:500) and phospho-CREB (1:500; Cell Signaling Technology). Finally, we tested substrates acting on SIE. These included phospho-(Tyr701)-Stat1 (1:250), Stat3 (1:500), phospho-(Tyr705)-Stat3 (1:250), and phospho-(Ser727)-Stat3 (1:300). All were purchased from Cell Signaling Technology. Targeted upstream regulators of many of these substrates were also detected including phospho-p90 RSK (1:500) and phospho-ERK 1/2 (1:500), which were also purchased from Cell Signaling Technology. A number of other antibodies were tested but were excluded from this report due to lack of antibody detection specificity.
Experiment 7: Tests of MEK 1/2 Inhibition. Inhibition of MEK 1/2 activity was accomplished with the MEK 1/2 inhibitor SL327 (gift from Dr. James Trzaskos; DuPont Pharmaceuticals, Wilmington, DE), which has the primary advantage of being active via systemic injections (Selcher et al., 1999) . SL327 was dissolved in DMSO and pretreated to animals 40 min before a saline or 2.4 g/kg alcohol injection (n ϭ 5/group). Animals were sacrificed 100 min after the second injection, and immunohistochemistry was performed for cFos as described above.
Results
Experiment 1: GABA-ergic Involvement in AlcoholInduced c-Fos Expression in EW Neurons. Administration of GABA-ergic antagonists produced significant changes in alcohol-induced c-Fos expression in the EW (Fig. 1, C and  D) . Specifically, pretreatment with 4 mg/kg bicuculline significantly attenuated alcohol-induced c-Fos expression [F(1,19) ϭ 100.31, p Ͻ 0.001]. Like bicuculline, pretreatment with 45 mg/kg PTZ significantly attenuated alcohol-induced c-Fos expression [F(1,20) ϭ 28.76, p Ͻ 0.001]. These doses of bicuculline and PTZ approach doses known to produce seizures (Johansson et al., 1996) ; however, we observed no convulsive effects in our study. Administration of the positive modulator of the GABA A receptor also produced significant effects. The neurosteroid 3␣5␣-P produced a dose-dependent increase in EW c-Fos expression ( Fig. 2A) . In particular, 10 mg/kg 3␣5␣-P produced a modest, statistically insignificant increase in c-Fos expression, whereas the 20 mg/kg 3␣5␣-P showed a significant increase in EW c-Fos expression. This dose of 3␣5␣-P in mice is expected to produce a similar locomotor response to 2.4 g/kg ethanol (Palmer et al., 2002) . Therefore, higher doses of 3␣5␣-P were not included. The benzodiazepine CDP showed a uniform, but significant, increase in c-Fos expression across all administered doses (Fig.  2B) . These elevations in c-Fos expression after both GABAergic agonists are significantly below that shown after alcohol administration (Fig. 2) .
Experiment 2: Opioid Involvement in Alcohol-Induced c-Fos Expression in EW Neurons. Pretreatment with 30 mg/kg naltrexone before 2.4 g/kg alcohol had no effect on alcohol-induced c-Fos expression (Fig. 3) . When morphine was administered at 10 and 100 mg/kg, however, a significant increase in EW c-Fos was detected (Fig. 3) . As was evident with the positive modulators of the GABA A complex, (Fig. 3) .
Experiment 3: Noradrenergic Involvement in Alcohol-Induced c-Fos Expression in EW Neurons. The nonselective ␣ 2 -adrenergic antagonist yohimbine produced a dose-dependent blockade of alcohol-induced c-Fos expression (Fig. 4) . Alcohol-induced c-Fos remained elevated when 20 mg/kg propranolol, a nonselective ␤-adrenergic antagonist, was administered before alcohol (Fig. 4) . Although only one dose of propranolol was administered, sedative effects were observed, indicating behavioral activity of the drug. To further characterize the ␣ 2 -adrenergic antagonist effects, two compounds were used to elucidate ␣ 2 -adrenoceptor subtypespecific mechanisms of alcohol-induced c-Fos expression in EW (Fig. 1, E and F) . First, 10 mg/kg ARC 239, a ␣ 2B/Cselective antagonist, showed no statistically significant changes in alcohol-induced c-Fos expression (Fig. 4) . Behaviorally, this dose of ARC 239 was extremely sedative. Second, we used 5 and 10 mg/kg RX 821002, which has been shown to be a ␣ 2A/D -selective antagonist (Trendelenburg et al., 1996) . When administered before alcohol, RX 821002 dose dependently diminished alcohol-induced c-Fos expression in EW neurons (Fig. 4) .
To further characterize the pharmacological mechanisms associated with c-Fos expression in EW neurons, we evaluated the effects of the noradrenergic system on CDP-induced and morphine-induced c-Fos expression in the EW (Fig. 5) . This was tested by pretreating a group of animals with 5 mg/kg yohimbine and subsequently injecting them with 20 mg/kg CDP. This resulted in a significant decrease in CDPinduced c-Fos in EW neurons, suggesting an adrenergic mechanism in GABA-induced c-Fos expression. We also tested the ability of 10 mg/kg RX 821002 to disrupt EW c-Fos expression, resulting from administration of 10 mg/kg morphine. Indeed, the ␣ 2 -adrenoceptor antagonist RX 821002 significantly blocked morphine-induced c-Fos expression, also suggesting a noradrenergic mechanism with morphineinduced c-Fos expression in EW neurons (Fig. 5) . 
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Administration of adrenergic agonists produced no effects on c-Fos expression in EW neurons (data not shown). Specifically, 0.1 and 0.5 mg/kg of the nonselective ␣ 2 -adrenergic agonist clonidine produced no changes in c-Fos expression. Interestingly, these same doses are capable of producing mydriatic changes in mice, which is thought to involve EW activity (Heal et al., 1989) . Furthermore, the nonselective ␣ 1 -adrenergic agonist cirazoline also showed no alterations in c-Fos expression at 0.5 and 1.0 mg/kg. Experiment 4: Morphological Characterization of Tyrosine Hydroxylase-Containing Neurons in the Edinger-Westphal Nucleus. Using tyrosine hydroxylase, the biosynthetic precursor of both dopamine and noradrenaline, it was found that TH-containing neurons project to EW (Fig. 6 ). Although these projections most likely represent the ventral noradrenergic bundle, which sends ascending noradrenergic fibers from the A7 brainstem nuclei to midbrain and forebrain structures, it is also possible for antibodies to TH to detect dopaminergic fibers. Moreover, the observed projections were seemingly stemming from the highly dopaminergic region of the ventral tegmental area (VTA). Therefore, we sought to investigate the influence of dopaminergic compounds on c-Fos expression in EW.
Experiment 5: Dopaminergic Involvement in Alcohol-Induced c-Fos Expression in EW Neurons. Pretreatment with 0.5 mg/kg of the dopamine antagonist haloperidol before alcohol administration resulted in a complete blockade of alcohol-induced c-Fos expression (Fig. 7) . Administration of both 1 and 10 mg/kg apomorphine resulted in no significant elevation in c-Fos expression (data not shown).
Experiment 6: Signal Transduction Cascades after Acute Alcohol Administration. Overall, relatively few changes were observed in the targeted upstream modulators of the c-Fos promotor at 5, 15, or 30 min after alcohol injection (Fig. 8) . In particular, no changes were observed in phospho-CREB in EW neurons, suggesting that the pathway targeting the Ca/CREB element is not involved in alcoholinduced c-Fos expression in the EW. Changes in phospho-CREB were observed in the paraventricular nucleus of hypothalamus. EW neurons were also absent of changes in phospho-Elk1 levels, which is one of the primary regulators of the SRE site, thus lending support to the hypothesis that the SRE is not involved in alcohol-induced c-Fos expression. Interestingly, however, alcohol produced significant elevations in serine 727-phosphorylated Stat3 in the nuclei of EW neurons at the 15-min time point (Fig. 9) . Tyrosine 705-phosphorylated Stat3, however, was not elevated at any time points after alcohol or saline treatment. EW neurons did not show any changes in other tested members of the Stat family, suggesting specificity for Stat3, with preferential phosphorylation activity at the serine 727. In addition to the changes in serine 727-phosphorylated Stat3, we observed changes in the upstream regulator of many substrates, phospho-ERK1/2. Specifically, significantly higher levels of phospho-ERK 1/2 were observed in EW neurons in animals receiving alcohol (Fig. 9) . As with the elevations noted with phosphoStat3, these changes were apparent at 15-min postinjection. No changes in other upstream regulators, including p90RSK, phospho-Stat1, and phospho-MAPK 38 were observed (data not shown).
Experiment 7: Expression of c-Fos in EW after Pretreatment of the MEK 1/2 Inhibitor SL327. In an attempt to evaluate the role of the MEK/ERK pathway in alcoholinduced c-Fos in EW neurons, we blocked MEK 1/2 activity pharmacologically with SL327. Administration of SL327 40 min before alcohol or saline treatment showed a dose-dependent blockade of c-Fos expression in EW neurons (Fig. 10) . Specifically, 50 mg/kg SL327 produced relatively no effect on alcohol-induced c-Fos expression. Pretreatment with 100 mg/kg SL327, however, completely blocked alcohol-induced c-Fos expression in EW neurons, suggesting an MEK/ERKdependent pathway.
Discussion
Alcohol-induced elevations in c-Fos in EW neurons result from both voluntary and involuntary alcohol administration. Recent data indicate that both routes of alcohol administration lead to c-Fos expression in cells containing the neuropeptide urocortin, which may function to regulate alcohol-induced hypothermia and alcohol consumption (Bachtell et al., 2002) . The findings presented herein suggest that, upon involuntary alcohol exposure, EW neurons are influenced by several neurotransmitter receptors. Specifically, it seems that GABA A receptor activation is necessary and sufficient for increased expression of c-Fos in EW neurons. This suggests that alcohol is acting directly upon GABA A receptors. This is supported by data showing that positive modulators of the GABA A receptor (e.g., CDP and 3␣ 5␣-P) lead to elevated c-Fos in EW neurons as well as data showing attenuation of alcohol-induced c-Fos upon GABA A antagonist pretreatment. In agreement with our findings are reports showing elevated c-Fos expression and increased urocortin mRNA in EW neurons upon treatment with benzodiazepines (Cutrera et al., 1993; Skelton et al., 2000) .
Alcohol actions at GABA A receptors do not, however, seem to be the only transmitter system involved. This is evidenced by the inability of either CDP or 3␣5␣-P to induce c-Fos expression in EW to levels comparable with that of alcohol alone. Furthermore, complete blockade of alcohol-induced c-Fos expression was observed by pretreatment of ␣ 2A/Dadrenoceptor and dopaminergic receptor antagonists. These receptors are therefore necessary for alcohol-induced c-Fos expression. Administration of direct agonists at these sites, however, suggests that these receptors are not sufficient for increased c-Fos expression in EW neurons. Thereby, neither the ␣ 2 -adrenoceptor agonist clonidine nor the dopaminergic agonist apomorphine produced significant elevations of EW c-Fos. The latter supports our previous data showing no increased EW c-Fos expression after cocaine administration, which is a potent activator of extracellular dopamine (Ryabinin et al., 2000) . The dopaminergic effects demonstrated in this report may represent nonspecific effects in that we only note dopaminergic modification with haloperidol, which is thought to have actions at serotonin receptors in addition to dopaminergic D2 receptors (for review, see Millan, 2000) . Regardless, it is believed that alcohol is acting directly at GABA A receptors, and this activity is modified by actions at ␣ 2A/D and dopaminergic receptors. Support for this claim The opioid system is not necessary for alcohol-induced c-Fos as was evidenced by the inability of naltrexone to modulate alcohol-induced c-Fos in the EW. Interestingly, the opioid system does seem sufficient for c-Fos expression in EW neurons in that morphine significantly elevates c-Fos levels. As was shown with CDP-and 3␣5␣-P-induced c-Fos expression, morphine-induced c-Fos was significantly below that produced by alcohol alone. Furthermore, morphine-induced c-Fos expression may be influenced by ␣ 2A/D -receptors in a similar manner to that of alcohol and CDP. This notion is supported by the data presented herein that shows that the ␣ 2A/D -antagonist RX 821002 blocks morphine-induced c-Fos expression in EW neurons. This finding is intriguing given data suggesting that morphine and fentanyl are acting directly on EW neurons to produce nociception and catalepsy, but not mydriasis, which is thought to be primarily mediated by postsynaptic ␣ 2A/D -receptors in EW (Kamenetsky et al., 1997) .
Taken together, it seems that there are several neurotransmitter systems operating to influence the EW upon alcohol intoxication. Furthermore, these data implicate the involvement of other nuclei upstream from the EW nucleus. Although thorough tracing experiments have not been performed to map the upstream targets of the EW upon alcohol exposure, our data suggest that dopaminergic/noradrenergic neurons expressing tyrosine hydroxylase may play an important role in EW neuronal activity. These neurons likely represent noradrenergic projection neurons of the ventral noradrenergic bundle that perhaps stem from the locus coeruleus (Breen et al., 1983) .
Support for this notion comes from a report that emphasizes that EW neurons are under the influence of two primary sources of input (Szabadi and Bradshaw, 1996) . The first source is a tonic inhibitory input likely stemming from the locus coeruleus (LC). Physiological and pharmacological evidence supports this idea, showing that this pathway releases noradrenaline onto inhibitory postsynaptic ␣ 2 -adrenoceptors to influence autonomic functions (Koss, 1986) . Supporting the notion that the LC is an upstream target of EW is evidence that alcohol decreases noradrenergic activity in the LC (Pohorecky and Brick, 1977) . This decrease is reversed by antagonists acting at ␣ 2 -adrenoceptors (Verbanck et al., 1991) . Interestingly, morphine also acts on LC neurons to decrease the activity of noradrenergic neurons (Aghajanian, 1978) . In any case, the influence of LC input onto EW neurons demands further study given the pharmacological evidence presented herein.
The second source of input to the EW involves an indirect pathway that is mediated through a non-noradrenergic mechanism. Given the evidence presented herein, it is tempting to assign this non-noradrenergic input to dopamine, perhaps originating in the VTA as the TH-positive projections and pharmacological data purport. This may occur via alcohol's actions in the VTA to increase dopaminergic activity (Bunney et al., 2000) . Contradictory to this hypothesis is data showing that agonists for dopamine do not produce c-Fos induction in EW. This is supported by our data showing that cocaine does not induce-c-Fos expression in EW neurons. Therefore, it is extremely likely that another source of input is modulating EW activity.
Physiological as well as morphological data suggest that EW neurons are influenced by an inhibitory input from the hypothalamus (Saper et al., 1976; Koss, 1986; Zheng et al., 1995) . Although the transmitter systems targeted herein do not address this notion, the existence of Neuropeptide Y Y5 receptors in the EW gives credence to this hypothesis (Grove et al., 2000) . Other evidence suggests that substance P projections from the olivary pretectal nucleus mediate EW activity through NK1 (Klooster et al., 1995 (Klooster et al., , 2000 . Therefore, it seems apparent that the receptor systems impacting EW neurons are quite complex and most likely involve a number of interactions occurring through both pre-and postsynaptic actions. Additionally, it is apparent from the results presented herein and previous work that input to the EW is Relatively low levels of expression, however, were observed in EdingerWestphal neurons at this same time point after 2.4 g/kg alcohol (B). Likewise, robust levels of phosphorylated CREB were detected in the paraventricular nucleus of the hypothalamus (C) 15 min after 2.4 g/kg alcohol, whereas no changes were detected in Edinger-Westphal neurons (D).
primarily inhibitory, and it is proposed herein that alcohol acts to disinhibit the tonic inhibitory influence through one or more of these upstream targets of the EW.
Aside from the transmitters systems, it is important to consider the downstream actions of the receptors in EW neurons and the type of intracellular events that are initiated through their activation. Interestingly, all of the receptors suspected to modulate alcohol-induced c-Fos expression in EW neurons (including Y5 and NK1 receptors) act to down-regulate adenylate cyclase activity. This alone is suggestive of a unique signal transduction cascade culminating in alcohol-induced c-Fos expression. Further suggesting that a unique cascade may be involved is the observation that c-Fos, but not Egr1 is induced after alcohol administration (Bachtell et al., 1999; Bachtell and Ryabinin, 2001 ). Indeed, a unique sequence of events was observed in our experiments. Thus, we did not find phospho-CREB to be increased at any of the time points analyzed. This indicates that adenylate cyclase activation of protein kinase A, and subsequent phosphorylation of CREB are not involved with alcohol-induced c-Fos expression in EW neurons. Thereby, we do not believe that the Ca/CRE site is responsible for alcohol-induced c-Fos expression in EW neurons. We also detected that the Elk1 phosphorylation was not up-regulated at any of the time points, suggesting that SRE actions are not responsible for alcohol-induced c-Fos expression.
Rather, we observed that serine 727-phosphorylated, but not tyrosine 705-phosphorylated Stat3 was enhanced after alcohol administration. This enhancement occurred at a similar time point to the alcohol-induced elevations in phosphorylation of ERK 1/2. The similar time course in elevations suggests that these are not causally related; however, more precise time intervals need to be analyzed to make definite conclusions on the relationship of these two proteins. It does seem, however, that ERK 1/2 phosphorylation is necessary for alcohol-induced c-Fos induction in the EW. This is evidenced by significant blockade of alcohol-induced c-Fos expression when the MEK 1/2 inhibitor SL327 was administered before alcohol. Taken together, the data implicate the activation of an MEK 1/2-ERK 1/2 pathway that may phosphorylate Stat3 upon alcohol exposure, which culminates in c-Fos expression. Interestingly, a similar pathway has been observed in tissue culture experiments where it was shown that MEK 1/2 phosphorylation of ERK 1/2 occurs simultaneously with serine 727 phosphorylation, but not tyrosine 705 phosphorylation, of Stat3 (Ceresa et al., 1997) .
Taken together, these findings provide important information for the development of research tools enabling the functional significance of alcohol-induced c-Fos expression in EW neurons to be revealed. Specifically, the data gathered in this report provide a first glance at the neurochemical mechanisms affected by alcohol in EW neurons and lend suggestions on how to directly manipulate it. Direct manipulation combined with behavioral analyses of alcohol sensitivity measures (e.g., alcohol-induced hypothermia and loss of righting reflex) and addiction models (e.g., alcohol drinking and conditioned place preference) will allow the determination of the role of EW during alcohol intoxication. 
